Home Ingredients Oleocanthal
Anti-InflammatoryCardiovascularAntioxidant

Oleocanthal

Olea europaea
Evidence Level
Limited
3 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Oleocanthal is a minor phenolic compound in fresh extra-virgin olive oil, and it is what makes a robust oil sting at the back of the throat. A 2005 Nature paper showed it inhibits the COX-1 and COX-2 enzymes in test-tube assays, and most of what has been written about it since is cell and mouse work. The human research that exists was done with olive oil or with an olive polyphenol extract rather than with oleocanthal on its own: two single-meal crossovers (9 and 10 people) found less platelet clumping in the hours after oleocanthal-rich oil, a 91-person one-month crossover found better antioxidant status and one changed inflammatory marker, and a 102-person 12-week trial of a 10 mg/day standardized extract that is roughly 80 percent oleocanthal and oleacein reported lower fasting glucose and blood pressure. No trial has tested oleocanthal itself for memory or brain ageing; the closest human work gave 25 people with mild cognitive impairment extra-virgin or refined olive oil for six months, and dementia-rating scores improved on both oils. Oleocanthal content in retail oil is not standardized and varies several-fold with cultivar, harvest date and storage, so a bottle rarely tells you how much you are getting.

Studied Dose 10 mg/day of a standardized olive polyphenol extract (about 80% oleocanthal plus oleacein) for 12 weeks in the metabolic syndrome trial. The two acute platelet studies each used a single 40 mL serving of olive oil; in the diabetes study that oil carried 250 or 500 mg/kg oleocanthal.
Active Compound Oleocanthal ((-)-decarboxymethyl ligstroside aglycone, dialdehydic form), a tyrosol ester. Not standardized in retail olive oil: content varies several-fold with cultivar, harvest date and storage, and most labels do not state it.

Benefits

Platelet activity after an olive oil meal

In two small randomized crossover studies, oil high in oleocanthal reduced platelet clumping measured in blood drawn in the hours after a meal: 9 healthy men given 40 mL of oil, and 10 people with type 2 diabetes given oil containing 250 or 500 mg/kg oleocanthal. Both were single-meal studies of a laboratory measurement, not of bleeding, clots or heart events.

Supported by Trial 1, Trial 3

Blood sugar and blood pressure: one 12-week trial

In a 12-week trial, 102 adults with metabolic syndrome took either 10 mg/day of a standardized olive polyphenol extract (about 80% oleocanthal and oleacein) or a placebo. The supplement group ended with lower fasting glucose (a 7.1 mg/dL difference), lower HbA1c (0.29 percentage points), lower systolic blood pressure (7.7 mmHg) and a BMI 1.15 units lower. The product is a mixture, not oleocanthal alone, the trial was registered on ClinicalTrials.gov seven months after it finished, and no independent group has repeated it.

Supported by Trial 1, Trial 3

Cardiovascular polyphenol intake

The EU allows olive oil to carry a claim that its polyphenols help protect blood lipids from oxidative damage. The condition is that the oil contains at least 5 mg of hydroxytyrosol and its derivatives per 20 g, and that 20 g of that oil is eaten daily. The claim belongs to the phenolic fraction as a whole, not to oleocanthal, which is one contributor among several.

Supported by Trial 1

Marker of olive oil quality

Oleocanthal content rises with cultivar choice, early harvest, and minimal processing and falls with prolonged storage or heat. The throat-sting it produces is widely used by olive oil tasters as a sensory marker that an EVOO retains its bioactive phenolic profile.

Supported by Trial 1, Trial 3

Inflammation markers: a small human change

The one human test of this was a one-month crossover in 91 adults with obesity and prediabetes who cooked with either oleocanthal-rich extra-virgin olive oil or ordinary olive oil. Of the inflammatory markers measured, only interferon-gamma differed between the two oils (p = 0.041), while total antioxidant status rose and lipid peroxides fell. In the separate 102-person supplement trial, C-reactive protein was among the secondary outcomes and was not reported among the markers that improved. The rest of the anti-inflammatory case is cell-system work.

Supported by Trial 1, Trial 3

Mechanism of action

1

Cyclooxygenase-1 and -2 inhibition

In test-tube enzyme assays oleocanthal inhibits COX-1 and COX-2, reducing conversion of arachidonic acid to prostaglandin precursors. Amounts reaching the blood from food are far below any drug dose, and in the human platelet crossover the authors reported that COX blockade did not appear to explain the fall in platelet aggregation they measured.

2

Amyloid transporters in mice, not in people

In cultured mouse brain endothelial cells and in normal C57BL/6 mice (not an Alzheimer's model), oleocanthal raised P-glycoprotein and LRP1 levels at the blood-brain barrier and sped clearance of injected radiolabelled amyloid-beta from the brain. No transporter measurement of this kind has been made in people. The closest human work, a six-month trial in 25 people with mild cognitive impairment, found less blood-brain-barrier leakage on MRI with extra-virgin than with refined olive oil, but it tested whole oil rather than oleocanthal.

3

Platelet aggregation, by a pathway that is not settled

In the two human crossover studies, oil rich in oleocanthal lowered platelet aggregation: collagen-stimulated aggregation two hours after the oil in 9 healthy men, and ADP- and thrombin-receptor-stimulated aggregation from 90 to 240 minutes after the meal in 10 people with type 2 diabetes. The size of the effect tracked oleocanthal intake, but total phenolic intake rather than oleocanthal alone tracked the fall in eicosanoid production, and the authors concluded cyclooxygenase blockade was not what produced the platelet result.

4

Modulation of inflammatory signalling proteins

Oleocanthal has been reported to bind and modulate macrophage migration inhibitory factor (MIF) and to suppress inflammatory transcription factor activity in cell systems, complementing its direct COX inhibition and supporting its profile as a multi-target anti-inflammatory food bioactive.

Clinical trials

1
Test-tube COX enzyme assay, not a trial in people
PubMed

2005 report in Nature. Purified oleocanthal was tested against COX-1 and COX-2 enzymes in the laboratory, and its throat sting was compared with that of ibuprofen solutions in tasters. No health outcome was measured in anyone.

None. Laboratory enzyme assays plus a taste comparison. No patients and no health outcome.

Oleocanthal inhibited COX-1 and COX-2 in a dose-dependent way in enzyme assays, with a potency the authors described as similar to ibuprofen. The throat sting of fresh extra-virgin olive oil tracked its oleocanthal content. Neither result is a measure of inflammation, pain or any other outcome in a person.

2
Mouse and cell study of amyloid clearance, not a human trial
PubMed

In vitro and in vivo study evaluating effects of oleocanthal on beta-amyloid clearance in cell models and wild-type mice. Outcomes: BBB transporter expression (P-gp, LRP1), brain Aβ40 levels. Published in ACS Chemical Neuroscience.

None. Cultured mouse brain endothelial cells and normal C57BL/6 mice. No people were studied.

Oleocanthal raised P-glycoprotein and LRP1 at the blood-brain barrier and increased clearance of injected radiolabelled amyloid-beta from mouse brain, with brain efflux rising from 62% to 80%. The mice were normal animals, not an Alzheimer's model, and no memory or cognitive outcome was measured.

3
Taste-panel study of throat sting, not a health trial
PubMed

Sensory study characterizing the throat-stinging irritation of oleocanthal in a panel of trained tasters. Outcomes: time-course of oropharyngeal irritation, individual variability in perception. Published in Chemical Senses.

Volunteers (50 to 84 per comparison) rating oleocanthal solutions in the mouth. A sensory study, not a health outcome trial.

Oleocanthal produced a stinging sensation localized to the oropharynx, peaking around 15 seconds after exposure and lasting beyond 3 minutes. Individual sensitivity varied widely between people. Ratings did not correlate with sensitivity to carbonation or to sweetness, so separate receptors seem to be involved. This describes how oleocanthal tastes, not what it does in the body.

Side effects and drug interactions

Common Potential side effects

Throat irritation and peppery stinging are intrinsic sensory effects, not adverse reactions.
A 12-week trial of a 10 mg/day olive polyphenol extract in 102 adults reported no serious adverse events. There is no longer-term supplement safety data.
Getting oleocanthal from oil means eating oil: 50 g of olive oil is about 440 calories, so it has to displace other fat rather than be added on top.
Platelet aggregation measured in blood samples fell for up to four hours after meals containing oleocanthal-rich oil, in a crossover of 10 people. Whether that translates into more bruising or bleeding has not been tested.
Rare olive allergy — discontinue if allergic reaction occurs.

Important Drug interactions

NSAIDs (ibuprofen, naproxen, aspirin): in one 10-person crossover, olive oil carrying 500 mg/kg oleocanthal reduced post-meal platelet aggregation about as much as a meal with 400 mg ibuprofen, so an additive effect is plausible rather than purely theoretical.
Anticoagulants and antiplatelet agents (warfarin, clopidogrel): a measured short-term fall in platelet aggregation makes this worth raising with a prescriber, though it has not been studied in people taking these drugs.
Antihypertensive medications — olive polyphenols may modestly lower blood pressure; monitor when combining.
Lithium: no study has tested oleocanthal or olive polyphenols alongside lithium. The concern is borrowed from prescription NSAIDs and has not been shown for this compound.

More Anti-Inflammatory Ingredients

Anti-Inflammatory
Limonene (D-Limonene)
Limonene (D-limonene) is a compound from citrus peels, used mainly for digestive comfort,…
Anti-Inflammatory
Levagen+® (PEA — Palmitoylethanolamide — Gencor)
Levagen+® is the branded bioavailable palmitoylethanolamide (PEA) from Gencor (Austin, TX)…
Anti-Inflammatory
BCM-95® / Curcugreen® (Bioavailable Standardized Curcumin)
BCM-95® — now rebranded as Curcugreen® — is a standardized turmeric extract developed by A…
Anti-Inflammatory
Brox-25® (Bromelain)
Brox-25® is a bromelain ingredient, the protein-digesting enzyme complex from pineapple (A…

Explore Other Ingredients

Metabolic Health
Inositol (Myo-Inositol)
Inositol is a naturally occurring sugar alcohol that acts as a secondary messenger in insu…
Metabolic Health
GlucoVantage® (Dihydroberberine)
GlucoVantage® is NNB Nutrition's branded dihydroberberine (DHB), a reduced form of berberi…
Metabolic Health
Fenugreek
Fenugreek is an aromatic seed used both as a culinary spice and a supplement. The best stu…

Frequently asked questions about Oleocanthal

What is oleocanthal used for?

Oleocanthal is a polyphenol in fresh extra-virgin olive oil responsible for its peppery throat sting. The human research on it is small and is mostly about platelet activity, antioxidant markers and blood sugar. No trial has tested oleocanthal itself for memory; a six-month trial of extra-virgin versus refined olive oil in 25 people with mild cognitive impairment saw dementia-rating scores improve on both oils.

Why is oleocanthal compared to ibuprofen?

Because both sting the throat and both inhibit the same COX enzymes in laboratory assays, a 2005 Nature paper drew the comparison and it stuck. The amounts in food are a fraction of a drug dose, no trial has tested oleocanthal for pain or inflammation the way ibuprofen is tested, and it is not a substitute for a medicine.

How do I get oleocanthal?

It is highest in fresh, robust extra-virgin olive oil, recognizable by the peppery throat sting it causes. Content is not standardized on labels and falls with age and heat, so the amount in any given bottle is unknown. Standardized olive polyphenol extract capsules do exist, and one 10 mg/day product has been through a single 12-week trial.

Is oleocanthal safe?

Olive oil itself has a long record of safe use, and a 12-week trial of a 10 mg/day olive polyphenol extract in 102 adults reported no serious adverse events. Longer supplement data do not exist. Because oleocanthal-rich oil measurably reduced platelet aggregation for a few hours after a meal, anyone on blood thinners or NSAIDs should mention it to their prescriber.

What is Oleocanthal?

Oleocanthal is a minor phenolic compound in fresh extra-virgin olive oil, and it is what makes a robust oil sting at the back of the throat. A 2005 Nature paper showed it inhibits the COX-1 and COX-2 enzymes in test-tube assays, and most of what has been written about it since is cell and mouse work.

What is the recommended dosage of Oleocanthal?

The clinically studied dose is 10 mg/day of a standardized olive polyphenol extract (about 80% oleocanthal plus oleacein) for 12 weeks in the metabolic syndrome trial. Always follow the product label and check with a healthcare provider for personal advice.

Is Oleocanthal safe, and does it have side effects?

For most healthy adults, Oleocanthal is well tolerated at studied doses. Reported effects can include: Throat irritation and peppery stinging are intrinsic sensory effects, not adverse reactions. A 12-week trial of a 10 mg/day olive polyphenol extract in 102 adults reported no serious adverse events. There is no longer-term supplement safety data. It may also interact with some medications. Oleocanthal is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Oleocanthal interact with any medications?

Possible interactions include: NSAIDs (ibuprofen, naproxen, aspirin): in one 10-person crossover, olive oil carrying 500 mg/kg oleocanthal reduced post-meal platelet aggregation about as much as a meal with 400 mg ibuprofen, so an additive effect is plausible rather than purely theoretical. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Oleocanthal?

NutraSmarts rates the evidence for Oleocanthal as Limited (2 out of 5). It is backed by 3 clinical trials and 11 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(11 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Beauchamp GK, Keast RS, Morel D, Lin J, Pika J, Han Q, Lee CH, Smith AB 3rd, Breslin PA. Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature. 2005;437(7055):45-6. doi: 10.1038/437045a.PubMedUsed to support: Purified oleocanthal inhibited COX-1 and COX-2 in laboratory enzyme assays in a dose-dependent way, at a potency the authors described as similar to ibuprofen, and the throat sting of fresh extra-virgin olive oil tracked its oleocanthal content in tasters. This 2005 Nature paper measured enzyme activity and taste. It did not measure inflammation, pain or any other health outcome in a person.
  2. Abuznait AH, Qosa H, Busnena BA, El Sayed KA, Kaddoumi A. Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies. ACS Chem Neurosci. 2013;4(6):973-82. doi: 10.1021/cn400024q.PubMedUsed to support: In cultured mouse brain endothelial cells and in normal C57BL/6 mice, oleocanthal increased P-glycoprotein and LRP1 at the blood-brain barrier and raised the brain efflux of injected radiolabelled amyloid-beta from 62% to 80%. The animals were healthy wild-type mice rather than an Alzheimer's model, and no memory or cognitive outcome was measured in any species.
  3. Cicerale S, Breslin PA, Beauchamp GK, Keast RS. Sensory characterization of the irritant properties of oleocanthal, a natural anti-inflammatory agent in extra virgin olive oils. Chem Senses. 2009;34(4):333-9. doi: 10.1093/chemse/bjp006.PubMedUsed to support: A sensory study in volunteers. Oleocanthal solutions produced a stinging sensation confined to the back of the throat, peaking about 15 seconds after exposure and lasting more than 3 minutes, and sensitivity varied widely between individuals with no correlation to carbonation or sweetness. This describes how oleocanthal is perceived, not what it does in the body.
  4. Parkinson L, Cicerale S. The Health Benefiting Mechanisms of Virgin Olive Oil Phenolic Compounds. Molecules. 2016;21(12):1734. doi: 10.3390/molecules21121734.PubMedUsed to support: A narrative review of olive oil phenolics. It describes anti-inflammatory, nutrigenomic, chemoprotective and anti-atherosclerotic activities reported for oleuropein, hydroxytyrosol and oleocanthal, and concludes that these activities are established in vitro and in animals and that intervention studies using biologically relevant concentrations in people are still required.
  5. Hohmann CD, Cramer H, Michalsen A, Kessler C, Steckhan N, Choi K, Dobos G. Effects of high phenolic olive oil on cardiovascular risk factors: A systematic review and meta-analysis. Phytomedicine. 2015;22(6):631-40. doi: 10.1016/j.phymed.2015.03.019.PubMedUsed to support: Pooled 8 crossover randomized trials with 355 participants comparing high-phenolic against low-phenolic or non-phenolic olive oil for 21 to 90 days. Systolic blood pressure was lower with the high-phenolic oil (SMD -0.52), though that result rests on only 69 of the participants, and oxidized LDL fell slightly (SMD -0.25, 95% CI -0.50 to 0.00, p = 0.05, n = 300), a confidence interval that reaches no effect. No effect was found on diastolic blood pressure, malondialdehyde, total cholesterol, HDL, LDL or triglycerides. The trials compared whole oils, so the result belongs to the olive phenolic fraction and not specifically to oleocanthal, and the reviewers named the small number of studies and participants as a limitation.
  6. Agrawal K, Melliou E, Li X, Pedersen TL, Wang SC, Magiatis P, Newman JW, Holt RR. Oleocanthal-rich extra virgin olive oil demonstrates acute anti-platelet effects in healthy men in a randomized trial. J Funct Foods. 2017;36:84-93. doi: 10.1016/j.jff.2017.06.046.PubMedUsed to support: A randomized crossover in 9 healthy men who each drank 40 mL of three extra-virgin olive oils on separate weeks, matched for total phenolic content but differing in oleocanthal and oleacein. Two hours after intake, maximum collagen-stimulated platelet aggregation was lower after the two oleocanthal-containing oils, and the size of the fall correlated with oleocanthal intake (R = 0.56, p = 0.002). Inhibition of eicosanoid production instead tracked total phenolic intake, and the authors concluded that cyclooxygenase blockade was not responsible for the platelet result. Nine participants and a single serving of each oil.
  7. Kaddoumi A, Denney TS Jr, Deshpande G, Robinson JL, Beyers RJ, Redden DT. Extra-Virgin Olive Oil Enhances the Blood-Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial. Nutrients. 2022;2022;14(23):.PubMedUsed to support: A 6-month randomized trial in people with mild cognitive impairment: 26 randomized and 25 completing, taking daily extra-virgin olive oil or refined olive oil. Blood-brain-barrier permeability on contrast MRI and brain function were the primary outcomes. Extra-virgin oil reduced barrier permeability and increased functional connectivity while refined oil did not, but clinical dementia rating and behavioural scores improved on both oils, and both lowered blood amyloid and tau ratios. The trial tested whole olive oil rather than oleocanthal, in 25 people, and the corresponding author is a co-founder and equity shareholder in an olive-oil company.
  8. Ruiz-García I, Ortíz-Flores R, Badía R, García-Borrego A, García-Fernández M, Lara E, Martín-Montañez E, García-Serrano S, Valdés S, Gonzalo M, et al. Rich oleocanthal and oleacein extra virgin olive oil and inflammatory and antioxidant status in people with obesity and prediabetes. The APRIL study: A randomised, controlled crossover study. Clin Nutr. 2023;42(8):1389-1398. doi: 10.1016/j.clnu.2023.06.027.PubMedUsed to support: 91 adults aged 40 to 65 with obesity and prediabetes replaced their cooking and table oil for one month with either an extra-virgin olive oil rich in oleocanthal and oleacein or a common olive oil, then crossed over. Inflammatory status was the primary outcome and of the panel measured only interferon-gamma reached a difference between the two oils (p = 0.041). Total antioxidant status rose and lipid and organic peroxides fell on the phenolic-rich oil compared with the common oil. Weight, BMI and blood glucose fell during the phenolic-rich oil period, but that was a change within that period rather than a measured difference between the two oils. The comparison is between two whole oils, so the result belongs to the phenolic fraction rather than to oleocanthal alone.
  9. Katsa ME, Ketselidi K, Kalliostra M, Ioannidis A, Rojas Gil AP, Diamantakos P, Melliou E, Magiatis P, Nomikos T. Acute Antiplatelet Effects of an Oleocanthal-Rich Olive Oil in Type II Diabetic Patients: A Postprandial Study. Int J Mol Sci. 2024;25(2):908. doi: 10.3390/ijms25020908.PubMedUsed to support: A randomized single-blind crossover in 10 people with type 2 diabetes who ate five isocaloric bread-based meals containing butter, butter plus 400 mg ibuprofen, or 40 mL of olive oil at low phenolic content, 250 mg/kg oleocanthal or 500 mg/kg oleocanthal. Platelet aggregation measured in blood samples fell in a dose-dependent way from 90 to 240 minutes after the oleocanthal meals, and the 500 mg/kg oil matched the ibuprofen meal. Glucose and lipid responses did not differ between meals. Ten participants, one meal each, and a laboratory measure of platelet function rather than any clinical event.
  10. Katsa ME, Gil APR, Makri EM, Papadogiannis S, Ioannidis A, Kalliostra M. Effect of oleocanthal-rich olive oil on postprandial oxidative stress markers of patients with type 2 diabetes mellitus. Food Nutr Res. 2024;2024;68:.PubMedUsed to support: The same 10 patients with type 2 diabetes as the postprandial platelet study, reported separately for redox markers. After meals containing olive oil with 250 or 500 mg/kg oleocanthal, the rise in thiobarbituric acid-reactive substances was blunted and red blood cell glutathione peroxidase activity was higher than after olive oil low in phenolics (p < 0.05), with the size of the effect depending on dose and on which marker was measured. This is the same single-meal crossover as the platelet paper, so the two publications are one study in ten people, not two.
  11. Samoutis G, Kyriakides TC, Demetriou N, Poulianiti E, Samouti G, Samouti S, Diamantakos P, Melliou E, Magiatis P. The impact of olive oil polyphenol supplementation on metabolic syndrome parameters The OleoMetS study: A randomized, controlled clinical trial. Clin Nutr ESPEN. 2026;71:102883. doi: 10.1016/j.clnesp.2025.102883.PubMedUsed to support: The only randomized placebo-controlled trial of an oral supplement rich in oleocanthal. 102 adults with metabolic syndrome took 10 mg/day of a standardized olive polyphenol extract (about 80% oleocanthal and oleacein, 18% oleuropein and ligstroside aglycones) or placebo for 12 weeks. Fasting glucose fell by 7.06 mg/dL and HbA1c by 0.29 percentage points versus placebo, with reductions also in BMI (1.15 units), systolic blood pressure (7.66 mmHg), triglycerides, oxidized LDL, uric acid and ALT, and no serious adverse events. C-reactive protein was a secondary outcome and was not reported among the markers that improved. The extract is a mixture rather than pure oleocanthal, the trial was entered on ClinicalTrials.gov in August 2025, seven months after it finished, and it has not been replicated by an independent group.